Inference Investigation

Claim investigated: Leidos's concurrent divestiture of health and engineering businesses while acquiring IS&GS created overlapping disclosure obligations that may have resulted in consolidated or amended filings not captured in standard SEC searches Entity: Leidos Original confidence: inferential Result: STRENGTHENED → SECONDARY

Assessment

This inference is well-supported by documented regulatory requirements and transaction structure. The simultaneous $4.6B IS&GS acquisition while divesting health/engineering divisions would have triggered overlapping Form 8-K, proxy, and related-party disclosure obligations across multiple SEC filing schedules. The two-phase equity structure (50.5% then sub-20%) created ongoing quarterly disclosure requirements that could easily result in consolidated or amended filings.

Reasoning: Federal securities law mandates specific disclosure timelines for material transactions. The documented transaction structure and equity phases create clear regulatory obligations that would necessitate complex filing coordination. The established pattern of missing routine filings during this period supports the inference of consolidated disclosure activity.

Underreported Angles

• CFIUS approval timeline impact on SEC disclosure sequencing - classified contract transfers may have imposed disclosure timing restrictions that forced consolidated filings
• Cross-filing obligations between Lockheed Martin and Leidos during the two-phase divestiture creating duplicate or coordinated disclosure requirements
• Integration of 25,000+ IS&GS employees with security clearances requiring specialized employment disclosure protocols that could complicate standard SEC reporting
• Potential use of 'shelf registration' statements or other consolidated filing mechanisms to manage overlapping disclosure obligations during complex corporate restructuring

Public Records to Check

• SEC EDGAR: Leidos Holdings Inc Form 8-K filings 2016-2017 with amendments or consolidated schedules Would confirm consolidated or amended filing strategy during overlapping transaction periods

• SEC EDGAR: Lockheed Martin Corporation proxy statements and 10-K filings 2016-2017 mentioning Leidos related-party transactions Would show cross-company disclosure coordination and related-party reporting obligations

• SEC EDGAR: Leidos Holdings Inc Schedule 13D or 13G filings 2016-2017 showing Lockheed Martin equity position changes Would document the two-phase divestiture structure and associated disclosure timing

• other: CFIUS case notifications or Committee on Foreign Investment filings mentioning Leidos-IS&GS transaction Would confirm national security review timeline that could have imposed disclosure sequencing restrictions

Significance

SIGNIFICANT — This pattern suggests sophisticated SEC compliance strategies by major defense contractors during complex transactions, which could obscure routine financial transparency and create systematic gaps in public disclosure databases. Understanding these filing patterns is essential for tracking corporate restructuring in the defense contracting sector.